Oncology Practice Management Issues


November 2014, Vol 4, No 7

Where Did My Data Go?

Teri U. Guidi, MBA, FAAMA

Data Management

There is no denying the trend of medical oncology practices being acquired by hospitals, whether through professional service agreements, employer–employee agreements, or something in between. The 2013 Community Oncology Practice Impact Report1—published by the Community Oncology Alliance—shows that in the [ Read More ]

Recent Drug Approvals

FDA News

FDA Approves First Anti–PD-1: Pembrolizumab Indicated for Advanced Melanoma The FDA approved the first ­­anti–programmed death receptor-1 (PD-1) therapy, pembrolizumab (Keytruda; Merck), for patients with unresectable or metastatic melanoma and disease progression after treatment with other melanoma therapy, such as [ Read More ]

New Clinical Trials Under Way

Clinical Trials Tracker

Erlotinib With or Without Bevacizumab The objective of this phase 2 study is to examine the efficacy of erlotinib with or without bevaciz­umab in patients with stage IV non–small-cell lung cancer with epidermal growth factor receptor (EGFR) mutations. Patients aged [ Read More ]